08.06.2013 Views

Psiquiatria - Faculdade de Medicina - UFMG

Psiquiatria - Faculdade de Medicina - UFMG

Psiquiatria - Faculdade de Medicina - UFMG

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

pacientes com predomínio <strong>de</strong> rituais compulsivos. A psico-cirurgia<br />

po<strong>de</strong> ser indicada em casos graves <strong>de</strong> TOC refratário, com<br />

melhora <strong>de</strong> até 25% a 30% dos pacientes.6<br />

Em revisão da literatura (MEDLINE, últimos 10 anos), encontramos<br />

cinco artigos nos quais a risperidona foi utilizada como<br />

adjuvante aos inibidores da recaptação da serotonina em pacientes<br />

com TOC refratário (não fazem referência à presença ou não<br />

<strong>de</strong> sintomas psicóticos).7-11 Em dois <strong>de</strong>sses estudos,7,8 o número<br />

<strong>de</strong> pacientes era muito pequeno (três e cinco pacientes com TOC<br />

refratário), mas 100% tiveram melhora com a adição <strong>de</strong> risperidona.<br />

Em um estudo <strong>de</strong> Saxena9 <strong>de</strong> 1996, 14 <strong>de</strong> 16 pacientes com<br />

TOC refratário (87%) tiveram melhora nos sintomas obsessivocompulsivos<br />

após três semanas da adição <strong>de</strong> risperidona ao tratamento,<br />

com dose média <strong>de</strong> 2,75 mg/dia. Ravizza10 publicou um<br />

trabalho em que sete <strong>de</strong> 14 pacientes refratários tiveram melhora<br />

clínica após a adição <strong>de</strong> risperidona a 150 mg <strong>de</strong> clomipramina.<br />

Todos os artigos sugerem que a adição <strong>de</strong> risperidona po<strong>de</strong><br />

ser útil em pacientes com TOC refratário. Andra<strong>de</strong>12 argumenta<br />

que os mecanismos <strong>de</strong> ação dos ISRS e da risperidona se oporiam<br />

apenas aparentemente, no sentido <strong>de</strong> que os primeiros liberam<br />

serotonina e o último bloqueia os receptores serotoninérgicos.<br />

Conforme essa concepção, a risperidona <strong>de</strong>veria agravar os sintomas<br />

obsessivo-compulsivos. Não obstante, os ISRS levam a uma<br />

down regulation dos receptores serotoninérgicos, sendo que este<br />

efeito po<strong>de</strong>ria ser potencializado, agora sim, através do bloqueio<br />

pela risperidona. Situação semelhante ocorreria na transmissão<br />

dopaminérgica, nas quais esses medicamentos também atuam.<br />

Há, <strong>de</strong> fato, relatos <strong>de</strong> caso evi<strong>de</strong>nciando piora dos sintomas obsessivos<br />

com o uso <strong>de</strong> antipsicóticos atípicos, porém isso parece<br />

ocorrer com muito mais freqüência na esquizofrenia com sintomas<br />

obsessivos do que em pacientes com TOC primário.13<br />

Summary<br />

N is an 18-year-old man who has presented invasive and recurrent<br />

thoughts for three years. In some of them his mother’s voice<br />

appears. Although consi<strong>de</strong>ring them irrational, he has un<strong>de</strong>r its influence.<br />

Mental and motor compulsions, with <strong>de</strong>crease in interpersonal<br />

contact, hygiene care and occupational functioning were<br />

observed. Stereotypic movements are also present. Common aspects<br />

between paranoic and obsessive patients are <strong>de</strong>scribed and<br />

the obsessive-compulsive disor<strong>de</strong>r may represent a spectrum that<br />

varies according to the patient's insight. After several therapeutic efforts<br />

there was a clinical improvement of the patient with clorimi-<br />

pramine 225 mg a day and risperidone 4 mg a day. Some studies suggest<br />

that the addition of risperidone could be useful in patients with<br />

resistant obsessive-compulsive disor<strong>de</strong>r.<br />

Key-words: Obsessive-compulsive Disor<strong>de</strong>r; Resistent Obsessive<br />

compulsive Disor<strong>de</strong>r; Psicotic Obsessive-compulsive Disor<strong>de</strong>r<br />

Referências Bibliográficas<br />

1. Von Gebsattel F. Antropologia Médica. Madrid: Ediciones<br />

Rialp AS, 1966:105-69.<br />

2. Jaspers, K. Psicopatologia Geral. 2ª Ed. Rio <strong>de</strong> Janeiro, São<br />

Paulo Atheneu, 1965:344-7.<br />

3. Insel TR, Akiskal HS. Obsessive-compulsive disor<strong>de</strong>r with<br />

psychotic features: a phenomenologic analysis. Am J<br />

Psychiatry 1986; 143:1527-33.<br />

4. Rosen I. The clinical significance of obsessions in schizophrenia.<br />

J Ment Sci 1957; 103:773-785.<br />

5. Hollan<strong>de</strong>r E. Obsessive-compulsive related disor<strong>de</strong>rs. American<br />

Psychiatric Press, 1993.<br />

6. Kaplan HI, Sadock BJ. Comprehensive textbook of psychiatry.<br />

6ª Ed. Baltimore: Willians & Wilkins, 1995:1218-27.<br />

7. Jacobsen FM. Risperidone in the treatment of affective illness<br />

and obsessive-compulsive disor<strong>de</strong>r. J Clin Psychiatry<br />

1995; 56:423-9.<br />

8. McDougle CJ, Fleischmann RL, Epperson CN, Wasylink S,<br />

Leckman JF, Price LH. Risperidone addition in fluvoxaminerefractory<br />

obsessive-compulsive disor<strong>de</strong>r: three cases. J Clin<br />

Psychiatry 1995; 56:526-8.<br />

9. Saxena S, Wang D, Bystritsky A, Baxter Jr LR. Risperidone<br />

augmentation of SRI treatment for refractory obsessive-compulsive<br />

disor<strong>de</strong>r. J Clin Psychiatry 1996; 57:303-6.<br />

10. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. Therapeutic<br />

effect and safety of adjunctive risperidone in refractory<br />

obsessive-compulsive disor<strong>de</strong>r (OCD). Psychopharmacol<br />

Bull 1996; 32:677-82.<br />

11. Stein DJ, Bouwer C, Hawkridge S, Emsley RA. Risperidone<br />

augmentation of serotonin reuptake inhibitors in obsessivecompulsive<br />

and related disor<strong>de</strong>rs. J Clin Psychiatry 1997;<br />

58:119-22.<br />

12. Andra<strong>de</strong> C. Obsessive-compulsive symptoms with risperidone<br />

(Dr. Andra<strong>de</strong> replies). J Clin Psychiatry 1999; 60:261-2.<br />

13. Saxena S. Obsessive-compulsive symptoms with risperidone<br />

(Dr. Saxena replies). J Clin Psychiatry 1999; 60:262.<br />

Casos Clin Psiquiat 1999; 1(1):36-39 39

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!